Research Shows GanedenBC30 Supports Protein Utilization
Ganeden Biotech, the makers of the patented probiotic GanedenBC30, today announced that new data showing the improvement of five protein utilization end points will be presented by Dr. Ralf Jäger, FISSN, CISSN, MBA at the 12th Annual International Society of Sports Nutrition (ISSN) conference, taking place June 11-13 in Austin, TX.